Researchers at The Ottawa Hospital awarded $3.9M from BioCanRx to develop new cancer immunotherapies April 9, 2025
Tumour engineering could provide a powerful new approach to make more cancer patients eligible for targeted immunotherapies September 26, 2024
BioCanRx Makes Patients Partners in Immunotherapy Research September 20, 2024 BioCanRx Makes Patients Partners in Immunotherapy Research
The Ottawa Hospital’s new campus to become a hub for biotherapeutics research and manufacturing thanks to $59M grant May 6, 2024 www.ottawahospital.on.ca
Beyond the spike: novel COVID vaccine candidate targets 7 viral proteins for strong immune response November 2, 2023
